Cochrane Abstracts
Levodopa for the treatment of restless legs syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Levodopa for the Treatment of Restless Legs Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434224/all/Levodopa_for_the_treatment_of_restless_legs_syndrome.
Levodopa for the treatment of restless legs syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434224/all/Levodopa_for_the_treatment_of_restless_legs_syndrome. Accessed April 30, 2025.
Levodopa for the treatment of restless legs syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434224/all/Levodopa_for_the_treatment_of_restless_legs_syndrome
Levodopa for the Treatment of Restless Legs Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434224/all/Levodopa_for_the_treatment_of_restless_legs_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Levodopa for the treatment of restless legs syndrome
ID - 434224
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434224/all/Levodopa_for_the_treatment_of_restless_legs_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
